Pesquisas alternativas:
comany carlos » company carlos (Expandir a Pesquisa), cony carlos (Expandir a Pesquisa), roman carlos (Expandir a Pesquisa)
rain comany » rain anomaly (Expandir a Pesquisa)
carlos node » carlos noda (Expandir a Pesquisa), carlos noe (Expandir a Pesquisa), carlos nodal (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
como can » como canal (Expandir a Pesquisa), como canon (Expandir a Pesquisa), como cande (Expandir a Pesquisa)
3 natl » 3 nacl (Expandir a Pesquisa), 3 nail (Expandir a Pesquisa), _ natl (Expandir a Pesquisa)
a rain » a raine (Expandir a Pesquisa), a raiz (Expandir a Pesquisa), a rainha (Expandir a Pesquisa)
c new » a new (Expandir a Pesquisa), _ new (Expandir a Pesquisa), c neu (Expandir a Pesquisa)
comany carlos » company carlos (Expandir a Pesquisa), cony carlos (Expandir a Pesquisa), roman carlos (Expandir a Pesquisa)
rain comany » rain anomaly (Expandir a Pesquisa)
carlos node » carlos noda (Expandir a Pesquisa), carlos noe (Expandir a Pesquisa), carlos nodal (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
como can » como canal (Expandir a Pesquisa), como canon (Expandir a Pesquisa), como cande (Expandir a Pesquisa)
3 natl » 3 nacl (Expandir a Pesquisa), 3 nail (Expandir a Pesquisa), _ natl (Expandir a Pesquisa)
a rain » a raine (Expandir a Pesquisa), a raiz (Expandir a Pesquisa), a rainha (Expandir a Pesquisa)
c new » a new (Expandir a Pesquisa), _ new (Expandir a Pesquisa), c neu (Expandir a Pesquisa)
1
Por Thompson, Hayley S., Shelton, Rachel C., Mitchell, Jamie, Eaton, Tara, Valera, Pamela, Katz, Anne
Publicado em 2013
“... are receptive to new media. A systematic literature review was conducted to assess the inclusion of these groups...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Llarena, Natalia C, Estevez, Samantha L, Tucker, Susan L, Jeruss, Jacqueline S
Publicado no J Natl Cancer Inst (2015)
“...% CI = 1.09 to 3.38) of tamoxifen. Other independent predictors of noninitiation included a diagnosis...”Publicado no J Natl Cancer Inst (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Yeung, Tsz-Lun, Sheng, Jianting, Leung, Cecilia S, Li, Fuhai, Kim, Jaeyeon, Ho, Samuel Y, Matzuk, Martin M, Lu, Karen H, Wong, Stephen T C, Mok, Samuel C
Publicado no J Natl Cancer Inst (2018)
“...–stroma crosstalk networks with prognostic value, which presents a unique opportunity for developing new...”Publicado no J Natl Cancer Inst (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound
Por Carlisle, Robert, Choi, James, Bazan-Peregrino, Miriam, Laga, Richard, Subr, Vladimir, Kostka, Libor, Ulbrich, Karel, Coussios, Constantin-C., Seymour, Leonard W.
Publicado em 2013
“...: Adenovirus (Ad) was “stealthed” with a new N-(2-hydroxypropyl)methacrylamide polymer, and circulation...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Waldron, Levi, Haibe-Kains, Benjamin, Culhane, Aedín C., Riester, Markus, Ding, Jie, Wang, Xin Victoria, Ahmadifar, Mahnaz, Tyekucheva, Svitlana, Bernau, Christoph, Risch, Thomas, Ganzfried, Benjamin Frederick, Huttenhower, Curtis, Birrer, Michael, Parmigiani, Giovanni
Publicado no J Natl Cancer Inst (2014)
“... make these difficult to compare or use in a clinically meaningful way. We sought to identify successful...”Publicado no J Natl Cancer Inst (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Mahale, Parag, Sturgis, Erich M., Tweardy, David J., Ariza-Heredia, Ella J., Torres, Harrys A.
Publicado no J Natl Cancer Inst (2016)
“...% to 8.3%) than in control subjects. Adjusted models showed a statistically significant association of HCV...”Publicado no J Natl Cancer Inst (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Hobbs, Brian P, Barata, Pedro C, Kanjanapan, Yada, Paller, Channing J, Perlmutter, Jane, Pond, Gregory R, Prowell, Tatiana M, Rubin, Eric H, Seymour, Lesley K, Wages, Nolan A, Yap, Timothy A, Feltquate, David, Garrett-Mayer, Elizabeth, Grossman, William, Hong, David S, Ivy, S Percy, Siu, Lillian L, Reeves, Steven A, Rosner, Gary L
Publicado no J Natl Cancer Inst (2018)
“...Traditionally, drug development has evaluated dose, safety, activity, and comparative benefit in a...”Publicado no J Natl Cancer Inst (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Lamhamedi-Cherradi, Salah-Eddine, Menegaz, Brian A., Ramamoorthy, Vandhana, Vishwamitra, Deeksha, Wang, Ying, Maywald, Rebecca L., Buford, Adriana S., Fokt, Izabela, Skora, Stanislaw, Wang, Jing, Naing, Aung, Lazar, Alexander J., Rohren, Eric M., Daw, Najat C., Subbiah, Vivek, Benjamin, Robert S., Ratan, Ravin, Priebe, Waldemar, Mikos, Antonios G., Amin, Hesham M., Ludwig, Joseph A.
Publicado no J Natl Cancer Inst (2016)
“... target of rapamycin (mTOR) have demonstrated remarkable, albeit short-lived, clinical responses in a...”Publicado no J Natl Cancer Inst (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Polato, Federica, Rusconi, Paolo, Zangrossi, Stefano, Morelli, Federica, Boeri, Mattia, Musi, Alberto, Marchini, Sergio, Castiglioni, Vittoria, Scanziani, Eugenio, Torri, Valter, Broggini, Massimo
Publicado em 2014
“...(+/−) mice on a C57BL/6J background) were used to assess DRAGO activity in vivo. Survival analyses were...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Zhang, Ben, Shu, Xiao-Ou, Delahanty, Ryan J., Zeng, Chenjie, Michailidou, Kyriaki, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Wen, Wanqing, Long, Jirong, Li, Chun, Dunning, Alison M., Chang-Claude, Jenny, Shah, Mitul, Perkins, Barbara J., Czene, Kamila, Darabi, Hatef, Eriksson, Mikael, Bojesen, Stig E., Nordestgaard, Børge G., Nielsen, Sune F., Flyger, Henrik, Lambrechts, Diether, Neven, Patrick, Wildiers, Hans, Floris, Giuseppe, Schmidt, Marjanka K., Rookus, Matti A., van den Hurk, Katja, de Kort, Wim L. A. M., Couch, Fergus J., Olson, Janet E., Hallberg, Emily, Vachon, Celine, Rudolph, Anja, Seibold, Petra, Flesch-Janys, Dieter, Peto, Julian, dos-Santos-Silva, Isabel, Fletcher, Olivia, Johnson, Nichola, Nevanlinna, Heli, Muranen, Taru A., Aittomäki, Kristiina, Blomqvist, Carl, Li, Jingmei, Humphreys, Keith, Brand, Judith, Guénel, Pascal, Truong, Thérèse, Cordina-Duverger, Emilie, Menegaux, Florence, Burwinkel, Barbara, Marme, Frederik, Yang, Rongxi, Surowy, Harald, Benitez, Javier, Zamora, M. Pilar, Perez, Jose I. A., Cox, Angela, Cross, Simon S., Reed, Malcolm W. R., Andrulis, Irene L., Knight, Julia A., Glendon, Gord, Tchatchou, Sandrine, Sawyer, Elinor J., Tomlinson, Ian, Kerin, Michael J., Miller, Nicola, Chenevix-Trench, Georgia, Haiman, Christopher A., Henderson, Brian E., Schumacher, Fredrick, Marchand, Loic Le, Lindblom, Annika, Margolin, Sara, Hooning, Maartje J., Martens, John W. M., Tilanus-Linthorst, Madeleine M. A., Collée, J. Margriet, Hopper, John L., Southey, Melissa C., Tsimiklis, Helen, Apicella, Carmel, Slager, Susan, Toland, Amanda E., Ambrosone, Christine B., Yannoukakos, Drakoulis, Giles, Graham G., Milne, Roger L., McLean, Catriona, Fasching, Peter A., Haeberle, Lothar, Ekici, Arif B., Beckmann, Matthias W., Brenner, Hermann, Dieffenbach, Aida Karina, Arndt, Volker, Stegmaier, Christa, Swerdlow, Anthony J., Ashworth, Alan, Orr, Nick, Jones, Michael, Figueroa, Jonine, Garcia-Closas, Montserrat, Brinton, Louise, Lissowska, Jolanta, Dumont, Martine, Winqvist, Robert, Pylkäs, Katri, Jukkola-Vuorinen, Arja, Grip, Mervi, Brauch, Hiltrud, Brüning, Thomas, Ko, Yon-Dschun, Peterlongo, Paolo, Manoukian, Siranoush, Bonanni, Bernardo, Radice, Paolo, Bogdanova, Natalia, Antonenkova, Natalia, Dörk, Thilo, Mannermaa, Arto, Kataja, Vesa, Kosma, Veli-Matti, Hartikainen, Jaana M., Devilee, Peter, Seynaeve, Caroline, Van Asperen, Christi J., Jakubowska, Anna, Lubiński, Jan, Jaworska-Bieniek, Katarzyna, Durda, Katarzyna, Hamann, Ute, Torres, Diana, Schmutzler, Rita K., Neuhausen, Susan L., Anton-Culver, Hoda, Kristensen, Vessela N., Grenaker Alnæs, Grethe I., Pierce, Brandon L., Kraft, Peter, Peters, Ulrike, Lindstrom, Sara, Seminara, Daniela, Burgess, Stephen, Ahsan, Habibul, Whittemore, Alice S., John, Esther M., Gammon, Marilie D., Malone, Kathleen E., Tessier, Daniel C., Vincent, Daniel, Bacot, Francois, Luccarini, Craig, Baynes, Caroline, Ahmed, Shahana, Maranian, Mel, Healey, Catherine S., González-Neira, Anna, Pita, Guillermo, Alonso, M. Rosario, Álvarez, Nuria, Herrero, Daniel, Pharoah, Paul D. P., Simard, Jacques, Hall, Per, Hunter, David J., Easton, Douglas F., Zheng, Wei
Publicado no J Natl Cancer Inst (2015)
“... established. Furthermore, the mechanisms of the association remain unclear. METHODS: We performed a meta...”Publicado no J Natl Cancer Inst (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Pozzi, G, Masala, L, Iannelli, F, Manganelli, R, Havarstein, L S, Piccoli, L, Simon, D, Morrison, D A
Publicado em 1996
“.... A new allele, comC2, was found in 13 strains, including the type 3 Avery strain, A66, while all...”Publicado em 1996
Obter o texto integral
Obter o texto integral
Artigo
12
Por Georgy, Smitha R., Cangkrama, Michael, Srivastava, Seema, Partridge, Darren, Auden, Alana, Dworkin, Sebastian, McLean, Catriona A., Jane, Stephen M., Darido, Charbel
Publicado no J Natl Cancer Inst (2015)
“... new treatment strategies targeting the GRHL3/GSK3B/c-MYC proto-oncogenic network....”Publicado no J Natl Cancer Inst (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José
Publicado em 2014
“... of Luminal A (10.7% vs 39.0%) and Basal-like (14.1% vs 23.4%) subtypes. The likelihood of cHER2-positivity...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
15
Por Kaseb, Ahmed O., Xiao, Lianchun, Hassan, Manal M., Chae, Young Kwang, Lee, Ju-Seog, Vauthey, Jean-Nicolas, Krishnan, Sunil, Cheung, Sheree, Hassabo, Hesham M., Aloia, Thomas, Conrad, Claudius, Curley, Steven A., Vierling, John M., Jalal, Prasun, Raghav, Kanwal, Wallace, Michael, Rashid, Asif, Abbruzzese, James L., Wolff, Robert A., Morris, Jeffrey S.
Publicado em 2014
“... with overall survival (OS): greater than 50ng/mL = 1 point; 26 to 50ng/mL = 2 points; and less than 26ng/mL = 3...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo